Delivery Order SPE2DB24D2216-SPE2DB26FGLZN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities, with a ceiling value of $1,026.67. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a discrete task under AmerisourceBergen's larger contract vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.74 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. This competitively awarded, firm fixed-price delivery order was issued on October 21, 2025, with an ultimate completion date of October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL pen format. This is a firm fixed-price contract with a ceiling value of $3,068.40 and an ultimate completion date of September 24, 2025. The contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin on June 11, 2025, with a ceiling value of $1,917.75. This is a firm fixed price delivery order issued under a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of June 12, 2025. This delivery order represents a small-value pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL formulations, with a ceiling value of $1,022.80. This delivery order represents a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities, with a contract value of $5,084.00 and completion deadline of September 24, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lantus SoloStar 100 unit/mL insulin in 3 mL formulations, with a ceiling value of $2,014.04. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, a pharmaceutical product used in diabetes management. The contract, awarded on August 22, 2025, carries a ceiling value of $2,439.56 with a firm fixed-price structure and an ultimate completion date of August 25, 2025. This non-competitive delivery order represents a relatively small-value transaction typical of routine pharmaceutical replenishment under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,928.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin in 3 mL quantities. The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and was awarded on August 14, 2025. This award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB26FGLZNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This $1,022.80 firm fixed-price contract represents a single delivery order with an ultimate completion date of October 24, 2025. The award was not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with the place of performance located in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC, designated SPE2DX, serves as the prime contract vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen Drug Corp provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related supplies across multiple therapeutic domains to federal healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/23/25 |